Notable from Our Podcast
In the November 10, 2020, podcast interview, Dr. Jeffrey Ratliff talks with Dr. Yvette Sheline about his study on the effect of escitalopram on CSF Aβ. Dr. Stacey Clardy speaks with Dr. Elizabeth Finger about her article on the neural effects of oxytocin on frontotemporal dementia.
Author Tip
E-Alerts
Want to easily keep track of new articles published in your field of interest? Sign up for e-alerts! You can customize alerts to be emailed to you about new articles by subject, title, and author. You can also get the table of contents of all, or some, of the Neurology journals. To sign up for e-alerts, please visit NPub.org/alerts.
From the AAN Press Room
Visit AAN.com/pressroom for the latest press releases
Study Suggests Brain Injuries May Evolve, Not Resolve, Over Time
Service members with concussions may have symptoms that continue to evolve up to 5 years after the initial injury. The findings challenge the idea that these individuals with chronic brain injuries maintain a relatively stable course of recovery. “Careful examination of combat-deployed service members, from the point of injury to one and five years later identified an evolution, not resolution, of symptoms,” said study author Christine L. Mac Donald, Ph.D., of the University of Washington School of Medicine, in Seattle. “In particular, a proportion of patients did worse on neurobehavioral and psychiatric evaluations when comparing one to five years, demonstrating the need to consider that not all chronic brain injury patients have the same experience in the years post injury.”
Comparison of clinical outcomes 1- and 5-years postinjury after combat concussion. doi.org/10.1212/WNL.0000000000011089
CME
Increasing Out-of-Pocket Costs for Neurologic Care for Privately Insured Patients
Page 94
Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study
Page 104
Most-Read Articles
As of November 16, 2020
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
G. McKhann, D. Drachman, M. Folstein, et al. 1984;34:939–944. doi.org/10.1212/WNL.34.7.939
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
J.F. Kurtzke. 1983;33:1444–1452. doi.org/10.1212/WNL.33.11.1444
Parkinsonism: onset, progression, and mortality
M.M. Hoehn and M.D. Yahr. 1967;17:427–442. doi.org/10.1212/WNL.17.5.427
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
D. Neary, J. S. Snowden, L. Gustafson, et al.1998;51:1546-1554. doi.org/10.1212/WNL.51.6.1546
Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop*G.
C. Román, T. K. Tatemichi, T. Erkinjuntti, et al. 1993;43:250-260. doi.org/10.1212/WNL.43.2.250
Neurosurgical horizons in Parkinson's disease
C.G. Goetz, M.R. De Long, R.D. Penn, and R.A.E. Bakay. 1993;43:1–7. doi.org/10.1212/WNL.43.1_Part_1.1
- © 2021 American Academy of Neurology
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.